BARRIER THERAPEUTICS
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. They currently have multiple product candidates based on intellectual property that they have licensed from third parties in clinical development, with four of these candidates in or entering Phase III clinical trials.
BARRIER THERAPEUTICS
Industry:
Biopharma Health Care Medical Therapeutics
Founded:
2002-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.barriertherapeutics.com
Total Employee:
51+
Status:
Closed
Technology used in webpage:
U.S. Server Location
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Anecova
Anecova is a life science company focused on the development and commercialization.
BioAxone Therapeutic
BioAxone Therapeutic is neuroscience company focused on the development and commercialization of technologies that target Rho signaling.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Gryphon Therapeutics
Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.
IBIS Therapeutics
IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprint™ Platform
Peninsula Pharmaceuticals
A biopharmaceutical company focused on the development and commercialization of antibiotics.
Respironics
BioRexis is a biopharmaceutical company that develops and produces biopharmaceuticals.
SMART Therapeutics
SMART Therapeutics - SMART Therapeutics is a biopharmaceutical company focused on discovery and development orally administered drugs.
Viridian Biosciences
Viridian is a biopharma incubator, founded to strengthen the link between scientific discovery and product commercialization.
Current Advisors List
Board_member
Current Employees Featured
Alfred Altomari COO @ Barrier Therapeutics
COO
Founder
Stock Details
Official Site Inspections
http://www.barriertherapeutics.com
- Host name: 66.54.49.4
- IP address: 66.54.49.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Barrier Therapeutics"
Barrier Therapeutics - Crunchbase Company Profile & Funding
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major …See details»
Barrier Therapeutics Company Profile 2024: Valuation, Investors ...
Barrier Therapeutics General Information Description. Developer and manufacturer of pharmaceuticals for dermatological therapeutics. The company provides Xolegel, a topical gel …See details»
Barrier Therapeutics Inc - Company Profile and News
Barrier Therapeutics, Inc. operates as a biopharmaceutical company. The Company discovers, develops, and commercializes portfolio of pharmaceutical products for the treatment of …See details»
Barrier Therapeutics to Merge Into Stiefel Laboratories
Jun 23, 2008 The price of $4.15 per share of Barrier Therapeutics' common stock represents a premium of approximately 73% to Barrier Therapeutics' average closing price for the past 30 …See details»
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics, …
The combination of Barrier Therapeutics with Stiefel Laboratories unites some of the most exciting assets in the dermatology industry. The acquisition of Barrier broadens Stiefel’s extensive …See details»
Barrier Therapeutics - LinkedIn
Barrier Therapeutics | 259 followers on LinkedIn. was a pharmaceutical company, engaged in the discovery, development, and commercialization of pharmaceutical products in the field of …See details»
BARRIER THERAPEUTI : cs to Merge Into Stiefel Laboratories
CORAL GABLES, Fla., June 23 /PRNewswire/ -- Stiefel Laboratories Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced it has …See details»
BARRIER THERAPEUTICS INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BARRIER THERAPEUTICS INC of Princeton Junction, NJ. Get the latest business insights from Dun & …See details»
Stiefel Laboratories to acquire Barrier Therapeutics - Dermatology …
Jun 23, 2008 - Stiefel Laboratories has announced it has signed a definitive merger agreement to acquire Barrier Therapeutics, according to PRNewswire. The transaction is valued at …See details»
Barrier Therapeutics - Overview, News & Similar companies
Barrier Therapeutics is a pharmaceutical company focused on the development and commercialization of products in the field of dermatology. Barrier Therapeutics currently …See details»
Barrier Therapeutics Inc. - CareersInPharmaceutical.com
Barrier Therapeutics Inc., is located at Princeton, NJ and is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field …See details»
Barrier Therapeutics - Contacts, Employees, Board Members, …
Organization. Barrier Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Barrier Therapeutics has 1 …See details»
Stiefel Labs to buy Barrier Therapeutics for $148 mln | Reuters
Jun 23, 2008 Stiefel Laboratories Inc will buy drug company Barrier Therapeutics Inc <BTRX.O> in a deal valued at about $148 million, combining the companies' dermatological products …See details»
Geert Cauwenbergh - Barrier Therapeutics (btrx) - The Wall Street ...
Oct 27, 2004 Previously, Dr. Cauwenbergh served as Vice President of Research & Development of the J&J Consumer Companies Worldwide, managing a global organization of …See details»
Barrier Therapeutics, Inc. Names New CEO - BioSpace
Jan 28, 2008 He started at Barrier Therapeutics as Vice President of Business Development, and moved rapidly into the position of Chief Commercial Officer and later Chief Operating …See details»
BARRIER THERAPEUTICS, INC. (BTRX) | Stock Discussion Forums
BARRIER THERAPEUTICS, INC. We are a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical …See details»
Barrier Therapeutics Close to Major Johnson Johnson Deal
It hasn''t been confirmed yet, but insiders say BarrierTherapeutics, a New Jersey biotech startup, is nearing a deal for a$46-million infusion of venture capitaSee details»
Barrier says drug candidate misses goal, shares fall | Reuters
Jun 14, 2007 Shares of Barrier Therapeutics Inc. <BTRX.O> lost more than half of their value in pre-market electronic trade on Thursday, after it said a mid- and late-stage study of a drug …See details»
Barrier takes second dermatologic product into Canada
Dec 6, 2005 Princeton, N.J.-Barrier Therapeutics Inc., a pharmaceutical company that specializes in dermatologic products, is now marketing and selling Vaniqa Cream …See details»
VCU by Barrier Theraputics Canada (Vaniqa)
The last patent will expire on May 27, 2013. Barrier Therapeutics Canada Inc. is the patentee for purposes of the Patented Medicine Prices Review Board (PMPRB). 1.4 On September 26, …See details»